NUCLEOLIN and breast carcinoma: We have previously demonstrated a nucleolin enrichment in breast cancer cells as nucleolin-binding F3-peptide-targeted pH-sensitive pegylated liposomes were significantly internalized by breast cancer cells [15], particularly by cancer stem cells subpopulations [16], in a ligand-dependent manner, in contrast with the absence of internalization by human non-cancer fibroblasts [17].